Northeast M&A and Life Sciences Innovation Forum Best Practices in M&A Deal Structuring, Financing, and Technology Innovation for the Life Sciences Sector

Event Details

Dec 06, 2016

9am - 5pm

Boston, MA

$595

Thomson Reuters Legal Executive Institute is pleased to present its 4th annual program on key developments and emerging trends impacting the northeast corporate M&A markets. This program offers rigorous educational content and abundant networking opportunities for transactional attorneys, bankers, M&A advisors and entrepreneurs throughout the northeast and New England region. Plan to attend this premier event and engage some of the brightest and most accomplished professionals in the business. Corporate counsel and M&A advisors should plan to attend this premier event.

Who Should Attend

Corporate Counsel, Vice Presidents and Directors responsible for:
  • M&A Deals and Transactions
  • Post-Merger M&A Integration
  • Human Resources
  • Talent Management and Leadership Development
  • Corporate Development

Event Details

Tuesday, Dec 06

8:30 AM
Registration & Networking Continental Breakfast
9:30 AM
Co-Chairs’ Welcome
9:45 AM
M&A Deal Activity and Industry Spotlight: Pharmaceutical and Biotech

This session will examine the top pharmaceutical and biotech deals to date and the challenges and obstacles that played a key role in their development. Key discussion points will delive into:

      • Top factors driving Medical Devices and Biotech deals
      • Product innovations and new technologies driving acquisitions
      • Regulatory considerations
      • Deal financing
      • Antitrust considerations

Moderator:
Carl O’Donnell, M&A Healthcare Reporter, Reuters News

Panelists:
Meredith Cook, Head of Global M&A, Dr. Reddy’s Laboratories
Luba Greenwood, Vice President, Mergers & Acquisitions, F. Hoffman-La Roche Ltd.
Jeff MannSenior Managing Counsel,  Med-Surg, Boston Scientific
Barbara Sosnowski, External R&D Innovation, Pfizer Inc.

10:45 AM
Networking Refreshment Break
11:15 AM
Start-Ups, Emerging Companies and Health Technology Innovation Forecast for 2017

New technology innovations and emerging startups across a broad range of industries are expected to drive deal activity and acquisitions in 2017. With increasing downward pressure on valuations, more assets will come to market, enticing recently inactive technology acquirers to start shopping again. This session will delve into:

      • 2016 tech innovation recap
      • 2017 deal outlook
      • Restaurant and retail sector
      • Tech innovations, startups and IPO activity expected to drive growth
      • Investor expectations

Moderator:
Scott R. Bleier,
Member, Morse, Barnes-Brown & Pendleton, PC

Panelists:
John Hession, Member, Morse, Barnes-Brown & Pendleton, PC
Mark Seka, Legal Counsel, Novartis
Deborah Zajac, Venture Partner, Touchdown Ventures

12:15 AM
Networking Luncheon
1:30 PM
M&A Deal Activity and Industry Spotlight: Medical Devices, Predictive Analytics and Healthcare Therapeutics

This session will examine the top medical devices and healthcare deals to date and the challenges and obstacles that played a key role in the development of the deal. This session will delve into:

      • Top factors driving deal activity within healthcare technology and among healthcare delivery providers
      • Deal financing & capital raising challenges
      • Product innovations and new technologies driving deal activity
      • Regulatory challenges on the horizon
      • Ensuring data protection through effective cyber-security defense safeguards

Moderator:
Tej Maini, MD, FACS, President, Maini Consulting

Panelists:
Nicholas A. Stawasz, Partner, Pepper Hamilton LLP
Ramesh Kumar, Chief Executive Officer & Co-Founder, zakipoint Health
William T. Whelan,  Co-Chair, Life Sciences Practice, Mintz Levin PC

2:30 PM
Networking Refreshment Break
2:45 PM
Once the Ink Dries: Making Practical Sense of Deal Terms and Aligning Those to Achieve a Seamless Post-Merger Integration

This session will provide a close look at how companies can effectively align all of the critical components of a merger or acquisition to allow for a seamless and relatively smooth integration. The session will dive into:

  • Aligning integration work and post-merger strategy with deal value drivers
  • Transitioning from due diligence and deal structure to integration
  • Alignment of human capital
  • Integration of IT and technology systems
  • Infrastructure planning
  • Day one planning
  • Employee communications

Moderator:
Carrie Frey – Principal, CLF Solutions Consulting, LLC

Panelists:
Tamara Dillon Senior Vice President, Human Resources, Akebia Therapeutics, Inc.
Kevin Smith Vice President & General Counsel, Danaher Life Sciences
Steve Walker
Director, Alliance Management and M&A Integration, Eli Lilly and Company

3:45 PM
Closing Comments
4:00 PM
Conclusion of Forum

Accreditation

The Colonnade Hotel

120 Huntington Avenue
Boston, MA 02116

Guest Rooms:

We have reserved a block of guest rooms at a rate of $199/night plus taxes. For web reservations, please click on the following hyperlink: Thomson Reuters. Alternatively, you may contact the hotel at 617.424.7000 and ask to be connected to Reservations. Please be sure to reference “The 4th Annual Northeast M&A/Private Equity Forum” to obtain the group rate. The cut-off date for guest room reservations at the group rate is Monday, November 14, 2016. Rooms are subject to availability. For assistance with guest room reservations, please contact our Conference Planner, Meghan Landis, at Meghan.landis@tr.com or 201.912.3042.

Parking:

Self Parking: Daily Event Rate: $25, Overnight: $48

Dress Code:

Business Casual. We recommend dressing in layers as meeting room temperatures tend to fluctuate.

More Info

Sponsors of This Event

×